About Vitara Biomedical
Vitara Biomedical is a private company based in Philadelphia, Pennsylvania, incorporated in 2019 in Delaware. It has reported $69,996,096 raised in three offerings on Form D since May 2020. Its chief executive is Bernard Lyons.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 11, 2024 | Oct 28, 2024 | $9,999,840of $49.9M target | 9 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Jul 19, 2022 | Jul 29, 2022amended Dec 6, 2023 | $39,996,256of $89.9M target | 9 | $4.4M | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Apr 30, 2020 | May 21, 2020 | $20,000,000of $30.0M target | 3 | $6.6M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $69,996,096 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vitara Biomedical's Form D filed Oct 28, 2024.
Earlier filings also listed Rosaleen Oskanian (executive officer, last listed Dec 2023), John Kelly (executive officer, last listed Dec 2023), James McGlone (president and chief executive officer, director, last listed Dec 2023), Nelson Hill (director, last listed May 2020), Jeffrey Kahn (executive officer, last listed May 2020) and Arthur Dantchik (director, last listed May 2020).